Creative Financial Designs’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $407K | Buy |
14,507
+1,748
| +14% | +$46.5K | 0.02% | 376 |
|
|
2025
Q4 | $318K | Buy |
12,759
+152
| +1% | +$3.83K | 0.02% | 391 |
|
|
2025
Q3 | $321K | Buy |
12,607
+129
| +1% | +$3.18K | 0.02% | 388 |
|
|
2025
Q2 | $302K | Sell |
12,478
-34
| -0.3% | -$793 | 0.02% | 400 |
|
|
2025
Q1 | $317K | Sell |
12,512
-32,370
| -72% | -$847K | 0.03% | 354 |
|
|
2024
Q4 | $1.19M | Buy |
44,882
+2,023
| +5% | +$54.9K | 0.1% | 177 |
|
|
2024
Q3 | $1.24M | Buy |
42,859
+3,728
| +10% | +$109K | 0.1% | 167 |
|
|
2024
Q2 | $1.09M | Buy |
39,131
+8,284
| +27% | +$228K | 0.1% | 167 |
|
|
2024
Q1 | $856K | Buy |
30,847
+6,151
| +25% | +$171K | 0.08% | 186 |
|
|
2023
Q4 | $711K | Buy |
24,696
+18,007
| +269% | +$544K | 0.07% | 196 |
|
|
2023
Q3 | $222K | Buy |
6,689
+1,630
| +32% | +$57.6K | 0.03% | 313 |
|
|
2023
Q2 | $186K | Sell |
5,059
-2,723
| -35% | -$106K | 0.02% | 355 |
|
|
2023
Q1 | $317K | Sell |
7,782
-30
| -0.4% | -$1.3K | 0.04% | 268 |
|
|
2022
Q4 | $400K | Buy |
7,812
+679
| +10% | +$32.6K | 0.06% | 231 |
|
|
2022
Q3 | $312K | Buy |
7,133
+1,268
| +22% | +$61.6K | 0.05% | 237 |
|
|
2022
Q2 | $307K | Sell |
5,865
-300
| -5% | -$15.3K | 0.05% | 244 |
|
|
2022
Q1 | $319K | Sell |
6,165
-53
| -0.9% | -$2.75K | 0.05% | 240 |
|
|
2021
Q4 | $367K | Buy |
6,218
+298
| +5% | +$14.8K | 0.06% | 230 |
|
|
2021
Q3 | $255K | Buy |
5,920
+391
| +7% | +$17.3K | 0.04% | 265 |
|
|
2021
Q2 | $216K | Buy |
5,529
+547
| +11% | +$21.3K | 0.04% | 276 |
|
|
2021
Q1 | $181K | Sell |
4,982
-887
| -15% | -$31.5K | 0.04% | 291 |
|
|
2020
Q4 | $216K | Sell |
5,869
-160
| -3% | -$5.87K | 0.05% | 243 |
|
|
2020
Q3 | $210K | Buy |
6,029
+3,106
| +106% | +$109K | 0.05% | 232 |
|
|
2020
Q2 | $91K | Buy |
2,923
+1,100
| +60% | +$37.4K | 0.03% | 303 |
|
|
2020
Q1 | $56K | Sell |
1,823
-316
| -15% | -$10.8K | 0.03% | 213 |
|
|
2019
Q4 | $79K | Sell |
2,139
-62
| -3% | -$2.21K | 0.04% | 212 |
|
|
2019
Q3 | $72K | Buy |
2,201
+66
| +3% | +$2.4K | 0.04% | 204 |
|
|
2019
Q2 | $88K | Buy |
2,135
+331
| +18% | +$13.1K | 0.05% | 188 |
|
|
2019
Q1 | $73K | Buy |
1,804
+1,006
| +126% | +$40.3K | 0.04% | 193 |
|
|
2018
Q4 | $33K | Buy |
798
+62
| +8% | +$2.57K | 0.02% | 231 |
|
|
2018
Q3 | $31K | Sell |
736
-3,710
| -83% | -$143K | 0.02% | 277 |
|
|
2018
Q2 | $153K | Buy |
4,446
+1,057
| +31% | +$36.1K | 0.09% | 148 |
|
|
2018
Q1 | $114K | Buy |
3,389
+6
| +0.2% | +$206 | 0.07% | 156 |
|
|
2017
Q4 | $116K | Sell |
3,383
-107
| -3% | -$3.65K | 0.08% | 158 |
|
|
2017
Q3 | $118K | Buy |
3,490
+2,548
| +270% | +$81.9K | 0.07% | 170 |
|
|
2017
Q2 | $30K | Sell |
942
-92
| -9% | -$2.9K | 0.02% | 281 |
|
|
2017
Q1 | $34K | Buy |
1,034
+410
| +66% | +$12.9K | 0.02% | 266 |
|
|
2016
Q4 | $19K | Buy |
+624
| New | +$19.1K | 0.02% | 324 |
|
Other funds holding PFE
VCM
VPM
Creative Financial Designs's PFE Position: Q1 2026 in Review
Creative Financial Designs increased its Pfizer (PFE) stake by 14% in Q1 2026, buying an estimated $46.5K and bringing the position to 14,507 shares worth $407K. The position accounts for 0.02% of the portfolio, ranked #376.
Creative Financial Designs first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.24M in Q3 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Creative Financial Designs held 14,507 shares of Pfizer worth $407K as of Q1 2026.
- Creative Financial Designs bought 1,748 Pfizer shares in Q1 2026, an estimated $46.5K.
- Pfizer made up 0.02% of Creative Financial Designs's portfolio in Q1 2026, its #376 holding.
- Creative Financial Designs first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- Creative Financial Designs's Pfizer position peaked at $1.24M in Q3 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.